Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK MEMBRUGGEN from Riemst, company number BE0437828108, closed financial year 2025 with a result of € -91 after tax. For that financial year APOTHEEK MEMBRUGGEN recorded a gross margin of € 4,286 and equity of € 13,708. Compared with financial year 2024, the result moved from € -384 to € -91. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 26, 2026.
€ 13,708
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -91
▲ 76 % less loss than in 2024
Profit after tax over the fiscal year.
€ 1,766
▼ 70% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -4,892.
Debts at end 2025
€ 8,550
▼ 21% vs 2024
€ 2,453 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 15,769
▼ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 20,286 | € 15,161 | € 19,837 | € 4,286 | ▼ 78% |
| Profit after taxes | € 1,849 | € 152 | € -384 | € -91 | ▲ € 293 |
| Equity | € 14,030 | € 14,183 | € 13,799 | € 13,708 | ▼ 1% |
| Total debts | € 104,256 | € 96,378 | € 89,851 | € 75,623 | ▼ 16% |
| Cash | € 10,341 | € 746 | € 5,846 | € 1,766 | ▼ 70% |
| Retained profit | € -4,570 | € -4,417 | € -4,801 | € -4,892 | ▼ € 91 |
| Bank debt | € 842 | € 8,766 | € 10,859 | € 8,550 | ▼ 21% |
| Balance sheet total | € 118,286 | € 110,561 | € 103,650 | € 89,331 | ▼ 14% |
Key figures of APOTHEEK MEMBRUGGEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to APOTHEEK MEMBRUGGEN?
What happened at APOTHEEK MEMBRUGGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 91. Source: NBB ↗
- Dammekens Farma BV became a director. NBB
- New establishment in Riemst. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,849 profit in 2022 to € 91 loss in 2025.
Best year ever: 2022, with € 1,849 profit.
A new publication or filing at APOTHEEK MEMBRUGGEN? We notify you, reason included.
Follow APOTHEEK MEMBRUGGENDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DAMMEKENS FARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK MEMBRUGGENBehind APOTHEEK MEMBRUGGEN is Dammekens Farma BV. The shares are held by DAMMEKENS FARMA (98.7%).
Directors
According to the 2025 annual accounts
Director · represented by Gudrun Dammekens
since 2017
Shareholders
98.7%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rijckerstraat 13
3770 Riemst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0437.828.108
- VAT number
- BE 0437.828.108
- Registered office
- Rijckerstraat 13, 3770 Riemst
- Names & denominations
- APOTHEEK MEMBRUGGEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 June 1989
- Peppol
- Active · Active since 28 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Activiteiten van medische beeldvorming en medische laboratoria
Detailhandel in drogisterijartikelen en onderhoudsproducten
Detailhandel in corrigerende brillen, lenzen en zonnebrillen
Gespecialiseerde detailhandel in optische en fotografische artikelen, foto- en filmapparatuur, optische en precisie-instrumenten
Medische laboratoria
Gespecialiseerde detailhandel in drogisterijartikelen en onderhoudsproducten
+3